ArticleBlood advances2025

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.

Evgenii Shumilov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.